Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Micoli

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Carbohydrate Polymers|April 7, 2023
Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A StreptococcusOlimpia Pitirollo, Roberta Di Benedetto, Pedro Henriques, et al.
Computational and Structural Biotechnology Journal|April 8, 2020
Structure, dynamics and immunogenicity of a catalytically inactive C<i>X</i>C chemokine-degrading protease SpyCEP from <i>Streptococcus pyogenes</i>Sophie McKenna, Enrico Malito, Sarah L Rouse, et al.
NPJ Vaccines|March 8, 2024
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccineValentino Conti, Omar Rossi, Kristen A Clarkson, et al.
Communications Biology|June 9, 2025
The characterization of Klebsiella pneumoniae associated with neonatal sepsis in low- and middle-income countries to inform vaccine designFrancesca Nonne, Mariagrazia Molfetta, Gianina Florentina Belciug, et al.
NPJ Vaccines|December 13, 2025
Evaluation of cross-functional antibody responses elicited by a four-component GMMA Shigella vaccineValentina Caradonna, Eleanna Sarakinou, Roberta Di Benedetto, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup XFrancesca Micoli, Maria Rosaria Romano, Marta Tontini, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2020
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM<sub>197</sub> conjugate vaccineFrancesca Micoli, Stefania P Bjarnarson, Melissa Arcuri, et al.
Mbio|July 21, 2022
Genetic and Structural Variation in the O-Antigen of Salmonella enterica Serovar Typhimurium Isolates Causing Bloodstream Infections in the Democratic Republic of the CongoSandra Van Puyvelde, Gianmarco Gasperini, Michael Biggel, et al.
NPJ Vaccines|September 5, 2023
A next-generation GMMA-based vaccine candidate to fight shigellosisOmar Rossi, Francesco Citiulo, Carlo Giannelli, et al.
The Lancet. Infectious Diseases|January 26, 2026
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trialIlse De Coster, Mohammad AbdelGhany, Eleanna Sarakinou, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Carbohydrate Polymers|April 7, 2023
Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A StreptococcusOlimpia Pitirollo, Roberta Di Benedetto, Pedro Henriques, et al.
Computational and Structural Biotechnology Journal|April 8, 2020
Structure, dynamics and immunogenicity of a catalytically inactive C<i>X</i>C chemokine-degrading protease SpyCEP from <i>Streptococcus pyogenes</i>Sophie McKenna, Enrico Malito, Sarah L Rouse, et al.
NPJ Vaccines|March 8, 2024
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccineValentino Conti, Omar Rossi, Kristen A Clarkson, et al.
Communications Biology|June 9, 2025
The characterization of Klebsiella pneumoniae associated with neonatal sepsis in low- and middle-income countries to inform vaccine designFrancesca Nonne, Mariagrazia Molfetta, Gianina Florentina Belciug, et al.
NPJ Vaccines|December 13, 2025
Evaluation of cross-functional antibody responses elicited by a four-component GMMA Shigella vaccineValentina Caradonna, Eleanna Sarakinou, Roberta Di Benedetto, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup XFrancesca Micoli, Maria Rosaria Romano, Marta Tontini, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2020
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM<sub>197</sub> conjugate vaccineFrancesca Micoli, Stefania P Bjarnarson, Melissa Arcuri, et al.
Mbio|July 21, 2022
Genetic and Structural Variation in the O-Antigen of Salmonella enterica Serovar Typhimurium Isolates Causing Bloodstream Infections in the Democratic Republic of the CongoSandra Van Puyvelde, Gianmarco Gasperini, Michael Biggel, et al.
NPJ Vaccines|September 5, 2023
A next-generation GMMA-based vaccine candidate to fight shigellosisOmar Rossi, Francesco Citiulo, Carlo Giannelli, et al.
The Lancet. Infectious Diseases|January 26, 2026
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trialIlse De Coster, Mohammad AbdelGhany, Eleanna Sarakinou, et al.
Pageof 13